Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
A Phase 1/1b Study of Single and Multiple Ascending Doses of TLC 6740 in Healthy Subjects, Including Evaluation of Food Effect and Potential Drug-Drug Interactions, and Preliminary Safety and Efficacy in Subjects With Obesity, With or Without Diabetes
Sponsor: OrsoBio, Inc
This PHASE1 trial investigates Healthy Subjects and Obesity and is currently actively recruiting participants. OrsoBio, Inc leads this study, which shows 12 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE1
-
Sep 2025 — Jan 2026 [monthly]
Recruiting PHASE1
-
Jun 2025 — Sep 2025 [monthly]
Recruiting PHASE1
-
Mar 2025 — Jun 2025 [monthly]
Recruiting PHASE1
-
Dec 2024 — Mar 2025 [monthly]
Recruiting PHASE1
▶ Show 7 earlier versions
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE1
-
Dec 2023 — Apr 2024 [monthly]
Recruiting PHASE1
-
Jun 2023 — Dec 2023 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting PHASE1
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OrsoBio, Inc
For direct contact, visit the study record on ClinicalTrials.gov .